Retinopathy Pigmentary Mental Retardation Overview

Save information for later
Sign Up

Learn About Retinopathy Pigmentary Mental Retardation

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Retinopathy Pigmentary Mental Retardation Local Doctors?

University Of North Carolina At Chapel Hill

2226 Nelson Hwy, Suite 200, 
Chapel Hill, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone and is rated as an Elite provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Usher Syndrome Type 2A, and X-Linked Retinitis Pigmentosa (XLRP). Dr. Iannaccone is currently accepting new patients.

Nagoya, JP 

Hiroko Terasaki practices in Nagoya, Japan. Terasaki and is rated as an Elite expert by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. Her top areas of expertise are Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Retinitis Pigmentosa, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Nijmegen, GE, NL 

Carel Hoyng practices in Nijmegen, Netherlands. Hoyng and is rated as an Elite expert by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. Their top areas of expertise are Late-Onset Retinal Degeneration, Stargardt Macular Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

What are the latest Retinopathy Pigmentary Mental Retardation Clinical Trials?
Rod and Cone Mediated Function in Retinal Disease

Background: Retinal diseases cause the loss of rod and cone photoreceptors. Symptoms include vision loss and night blindness. Researchers want to learn about rod and cone function in healthy people and people with retinal disease. They want to know if how well a person sees in the dark can test the severity of retinal disease.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls

Background: - Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) all affect the retina, the light sensing area at the back of the eye. Doctors cannot safely obtain retinal cells to study these diseases. However, cells collected from hair follicles, skin, and blood can be used for research. Researchers want to collect cells from people...